Header Logo

Connection

Trudy Morrison to Antibodies, Viral

Back to Details
This is a "connection" page, showing publications Trudy Morrison has written about Antibodies, Viral.
Trudy Morrison
Connection Strength
3.556
Antibodies, Viral
  1. Blanco JCG, Cullen LM, Kamali A, Sylla FYD, Boukhvalova MS, Morrison TG. Evolution of protection after maternal immunization for respiratory syncytial virus in cotton rats. PLoS Pathog. 2021 12; 17(12):e1009856.
    View in: PubMed
    Score: 0.660
  2. McGinnes Cullen L, Schmidt MR, Morrison TG. Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein-Containing Virus-Like Particles. J Virol. 2019 05 01; 93(9).
    View in: PubMed
    Score: 0.548
  3. Cullen LM, Schmidt MR, Morrison TG. The importance of RSV F protein conformation in VLPs in stimulation of neutralizing antibody titers in mice previously infected with RSV. Hum Vaccin Immunother. 2017 12 02; 13(12):2814-2823.
    View in: PubMed
    Score: 0.482
  4. Murawski MR, McGinnes LW, Finberg RW, Kurt-Jones EA, Massare MJ, Smith G, Heaton PM, Fraire AE, Morrison TG. Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology. J Virol. 2010 Jan; 84(2):1110-23.
    View in: PubMed
    Score: 0.285
  5. Blanco JCG, Cullen LM, Kamali A, Sylla FYD, Boukhvalova MS, Morrison TG. Development of Respiratory Syncytial Virus Vaccine Candidates for the Elderly. Viruses. 2023 05 31; 15(6).
    View in: PubMed
    Score: 0.182
  6. McGinnes Cullen L, Luo B, Wen Z, Zhang L, Durr E, Morrison TG. The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine Candidate. J Virol. 2023 01 31; 97(1):e0190022.
    View in: PubMed
    Score: 0.177
  7. Blanco JCG, Cullen LM, Kamali A, Sylla FYD, Chinmoun Z, Boukhvalova MS, Morrison TG. Correlative outcomes of maternal immunization against RSV in cotton rats. Hum Vaccin Immunother. 2022 12 30; 18(7):2148499.
    View in: PubMed
    Score: 0.176
  8. Blanco JCG, Fernando LR, Zhang W, Kamali A, Boukhvalova MS, McGinnes-Cullen L, Morrison TG. Alternative Virus-Like Particle-Associated Prefusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus. J Virol. 2019 12 01; 93(23).
    View in: PubMed
    Score: 0.143
  9. Blanco JCG, Pletneva LM, McGinnes-Cullen L, Otoa RO, Patel MC, Fernando LR, Boukhvalova MS, Morrison TG. Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model. Nat Commun. 2018 05 15; 9(1):1904.
    View in: PubMed
    Score: 0.129
  10. Cullen LM, Blanco JC, Morrison TG. Cotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein. J Transl Med. 2015 Nov 05; 13:350.
    View in: PubMed
    Score: 0.108
  11. McGinnes Cullen L, Schmidt MR, Kenward SA, Woodland RT, Morrison TG. Murine immune responses to virus-like particle-associated pre- and postfusion forms of the respiratory syncytial virus F protein. J Virol. 2015 Jul; 89(13):6835-47.
    View in: PubMed
    Score: 0.104
  12. Schmidt MR, McGinnes-Cullen LW, Kenward SA, Willems KN, Woodland RT, Morrison TG. Modification of the respiratory syncytial virus f protein in virus-like particles impacts generation of B cell memory. J Virol. 2014 Sep 01; 88(17):10165-76.
    View in: PubMed
    Score: 0.098
  13. Morrison TG. Meeting report VLPNPV: Session 3: Immune responses. Hum Vaccin Immunother. 2014; 10(10):3064-7.
    View in: PubMed
    Score: 0.095
  14. Schmidt MR, McGinnes LW, Kenward SA, Willems KN, Woodland RT, Morrison TG. Long-term and memory immune responses in mice against Newcastle disease virus-like particles containing respiratory syncytial virus glycoprotein ectodomains. J Virol. 2012 Nov; 86(21):11654-62.
    View in: PubMed
    Score: 0.086
  15. McGinnes LW, Gravel KA, Finberg RW, Kurt-Jones EA, Massare MJ, Smith G, Schmidt MR, Morrison TG. Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins. J Virol. 2011 Jan; 85(1):366-77.
    View in: PubMed
    Score: 0.076
  16. McGinnes LW, Pantua H, Laliberte JP, Gravel KA, Jain S, Morrison TG. Assembly and biological and immunological properties of Newcastle disease virus-like particles. J Virol. 2010 May; 84(9):4513-23.
    View in: PubMed
    Score: 0.073
  17. Pantua H, McGinnes LW, Leszyk J, Morrison TG. Characterization of an alternate form of Newcastle disease virus fusion protein. J Virol. 2005 Sep; 79(18):11660-70.
    View in: PubMed
    Score: 0.053
  18. Blanco JCG, Boukhvalova MS, Morrison TG, Vogel SN. A multifaceted approach to RSV vaccination. Hum Vaccin Immunother. 2018 07 03; 14(7):1734-1745.
    View in: PubMed
    Score: 0.032
  19. McGinnes LW, Morrison TG. Modulation of the activities of HN protein of Newcastle disease virus by nonconserved cysteine residues. Virus Res. 1994 Dec; 34(3):305-16.
    View in: PubMed
    Score: 0.025
  20. Sergel T, McGinnes LW, Peeples ME, Morrison TG. The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation. Virology. 1993 Apr; 193(2):717-26.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.